Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study.
Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study. J Cataract Refract Surg. 2018 Oct; 44(10):1236-1246.
View in:
PubMed
subject areas
Administration, Ophthalmic
Adult
Aged
Aged, 80 and over
Anterior Chamber
Dexamethasone
Drug Delivery Systems
Endophthalmitis
Endpoint Determination
Female
Glucocorticoids
Humans
Inflammation
Intraocular Pressure
Lens Implantation, Intraocular
Male
Middle Aged
Phacoemulsification
Prednisolone
Prospective Studies
Treatment Outcome
Visual Acuity
authors with profiles
Kerry D. Solomon